ETFs positioned on Virbac

Name YTD change Weight AuM
+7.99% - 5,871 M€
+9.73% - 67 M€
+0.76% - 51 M€
+8.20%0.53% 701 M€
+6.19%0.29% 1,025 M€
+4.29%0.28% 458 M€
+5.88%0.28% 335 M€
+3.80%0.28% 6 M€
+10.42%0.19% 3,620 M€
+11.49%0.16% 241 M€
+11.73%0.16% 121 M€
+8.27%0.14% 8 M€
+10.17%0.13% 336 M€
-9.32%0.13% 336 M€
+2.88%0.11% 184 M€
+13.17%0.08% 901 M€
-20.91%0.08% 901 M€
+5.18%0.06% 5,679 M€
+3.29%0.06% 12,001 M€
+16.16%0.05% 12 M€
+5.40%0.05% 679 M€
+10.34%0.05% 19 M€
+18.90%0.05% 160 M€
+6.73%0.05% 13,445 M€
+9.50%0.05% 258 M€
+17.00%0.04% 475 M€
+6.57%0.04% 366 M€
+3.84%0.04% 67 M€
+5.86%0.03% 361 M€
+9.85%0.03% 3,151 M€
+12.73%0.02% 8,963 M€
+10.43%0.02% 77 M€
+11.94%0.02% 679 M€
+15.86%0.02% 13 M€
+16.33%0.02% 153 M€
-.--%0.02% 3 M€
+10.08%0.02% 0 M€
-.--%0.02% 19 M€
+12.18%0.02% 2,014 M€
-0.73%0.02% 675 M€
+10.49%0.02% 151 M€
+7.95%0.02% 41 M€
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
6,442